Data / Form D filings / Medical 21, Inc.
Medical 21, Inc.: Form D filings
Medical 21, Inc., a biotechnology company in Plymouth, MN, filed 12 Form D notices with the SEC between 2016 and 2026. The latest, on October 23, 2026, reports $550,000 sold of a $20 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3700 Annapolis Lane North Suite 105, Plymouth, MN, 55447
- Phone
- (612) 670-5507
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Minnesota
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1673688
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | New notice | $20,000,000 | $550,000 | $19,450,000 | 3 | Sep 17, 2026 | sec.gov |
| Aug 21, 2025 | Amendment | $20,000,000 | $10,017,500 | $9,982,500 | 39 | Feb 9, 2023 | sec.gov |
| Jul 29, 2024 | Amendment | $10,000,000 | $5,217,500 | $4,782,500 | 29 | Feb 9, 2023 | sec.gov |
| Jul 31, 2023 | Amendment | $10,000,000 | $1,860,000 | $8,140,000 | 17 | Feb 9, 2023 | sec.gov |
| Apr 14, 2023 | New notice | $10,000,000 | $430,000 | $9,570,000 | 4 | Feb 9, 2023 | sec.gov |
| Sep 20, 2022 | New notice | $20,000,000 | $2,500,000 | $17,500,000 | 1 | Sep 13, 2022 | sec.gov |
| Jan 12, 2021 | Amendment | $10,000,000 | $3,000,000 | $7,000,000 | 15 | Feb 22, 2019 | sec.gov |
| Jan 16, 2020 | Amendment | $10,000,000 | $1,140,000 | $8,860,000 | 12 | Feb 22, 2019 | sec.gov |
| Jan 8, 2019 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
| Aug 1, 2018 | New notice | $4,000,000 | $750,000 | $3,250,000 | 5 | Dec 18, 2017 | sec.gov |
| Sep 1, 2017 | New notice | $15,000,000 | $250,000 | $14,750,000 | 1 | Aug 23, 2017 | sec.gov |
| May 19, 2016 | New notice | $2,000,000 | $200,000 | $1,800,000 | 2 | Apr 11, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Manny Villafana | Executive Officer, Director | |
| Eric Solien | Executive Officer | |
| Jeff Vreeman | Executive Officer | |
| Andrea Sweeney | Executive Officer |
Other biotechnology companies in Minnesota that filed recently
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Oct 19, 2026 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Medical 21, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.